🔎 Trials Near Me

Akèy › Menenjyom › New York › New York City

Etid klinik pou Menenjyom nan New York City, NY

8 etid pou Menenjyom ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Ap rekriteFaz 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Weill Cornell Medical Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT02523014

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Ap rekriteFaz 2
  • NYU Lagone Health, New York
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06955169

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Ap rekriteFaz 2
  • Memorial Sloan-Kettering Cancer Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Ap rekriteFaz 2
  • New York University Langone Medical Center, New York
Laj 12 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04374305

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

Ap rekriteFaz 2
  • NYU- Langone Health, New York
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07533942

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Ap rekriteFaz 2
  • Memorial Sloan Kettering Cancer Center, New York
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT05425004

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Ap rekriteFaz 4
  • New York-Presbyterian/Weill Cornell Medical Center, New York
Laj 18 a 99 · Tout sèks · Mizajou Feb 27, 2026 · NCT06377371

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

Ap rekriteFaz 4
  • Weill Cornell Medicine, New York
Laj 18 a 100 · Tout sèks · Mizajou Nov 21, 2025 · NCT04081701

Etid Menenjyom nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.